TBRC’s Machine Tools research report expands on key drivers, trends, and growth opportunities in the market. LONDON, June 23, 2022 /PRNewswire/ — New product innovations have emerged as the new key trend gaining popularity in the machine tools market. Major companies operating in the…
Related Posts
NACCO INDUSTRIES ANNOUNCES DATES OF 2022 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL
CLEVELAND, July 26, 2022 /PRNewswire/ — NACCO Industries® (NYSE:NC) will release its 2022 Second Quarter financial results and will file…
IMERYS RELEASES NEW PRODUCT: ImerShield™ Flame Retardants
ROSWELL, Ga., Aug. 1, 2022 /PRNewswire/ — Imerys introduces ImerShield™ solutions. ImerShield™ performance minerals are mineral-based synergists developed for flame…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.